On this day in Santa Clarita history, MannKind Corporation announced the FDA approval of AFREZZA, a fast-acting diabetes medication that is taken through inhalation. The medicine was introduced as an alternative to injection; patients are given an inhaler to use before meals, with the levels peaking 12 to 15 minutes after administration and lasting up to 3 hours. “Approval of ...

Alfred E. Mann, Chairman Emeritus of MannKind Corp. died of natural causes on Thursday at age 90. Don’t miss a thing. Get breaking KHTS Santa Clarita News Alerts delivered right to your inbox. Mann was the Chairman of the Board of MannKind from 2001 until Feb. 2016 and, from Nov. 2003 until Jan. 2015, was its Chief Executive Officer. He founded and largely funded 14 companies in his career. ...

The MannKind Corp. announced that it has receive the FDA approval for its candidate diabetes treatment, Afrezza. The announcement came after the close of trading Friday.